Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retagliptin Phosphate + Metformin vs Placebo + Metformin in Type 2 Diabetes
CTR20212334Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of retagliptin in type 2 diabetes mellitus (T2DM), sponsored by Hengrui Therapeutics. Started Sep 2021; status: completed.
02
Drugs
retagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20212334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212334.